GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 65 days ( 0 % )
Last Price $1.03 0 %
High/ Low $1.03 - $1.03 0%
Chg 7 Days N/A $1.03 $1.03
Chg 30 Days N/A $1.03 $1.03
Chg 12 mos 120.56 % $0.467 $1.03
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 77.38 % Width: 78.45 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $1.64 - $2.92 59.02 % - 183.77 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2023-07-17 - 74 days
Long MA avg 12 mos Buy 2023-10-11 - 14 days
Short/Long MA avg 12 mos Buy 2023-10-11 - 14 days
Pivot Short Sell 2023-10-27 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interfero... SPPI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT